THERIVA BIOLOGICS, INC. (TOVX)
Theriva™ Biologics anuncia los resultados del ensayo clínico de Fase I con VCN-01 para el cáncer de cabeza y cuello, publicados en la revista *Clinical Cancer Research*
Theriva™ Biologics anuncia los resultados del ensayo clínico de Fase I con VCN-01 para el cáncer de cabeza y cuello, publicados en la revista *Clinical Cancer Research*
Net Asset Value(s)
Statement regarding intention to fundraise
Dividend Declaration
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law Firm
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in SES AI Corporation of Class Action Lawsuit and Upcoming Deadlines - SES
Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Calix, Inc. of Class Action Lawsuit and Upcoming Deadlines - CALX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP